Literature DB >> 27996334

Postnatal Growth and Retinopathy of Prematurity Study: Rationale, Design, and Subject Characteristics.

Gil Binenbaum1,2, Lauren A Tomlinson1.   

Abstract

PURPOSE: Postnatal-growth-based predictive models demonstrate strong potential for improving the low specificity of retinopathy of prematurity (ROP) screening. Prior studies are limited by inadequate sample size. We sought to study a sufficiently large cohort of at-risk infants to enable development of a model with highly precise estimates of sensitivity for severe ROP.
METHODS: The Postnatal Growth and ROP (G-ROP) Study was a multicenter retrospective cohort study of infants at 30 North American hospitals during 2006-2012. A total of 65 G-ROP-certified abstractors submitted data to a secure, web-based database. Data included ROP examination findings, treatments, complications, daily weight measurements, daily oxygen supplementation, maternal/infant demographics, medical comorbidities, surgical events, and weekly nutrition. Data quality was monitored with system validation rules, data audits, and discrepancy algorithms.
RESULTS: Of 11,261 screened infants, 8334 were enrolled, and 2927 had insufficient data due to transfer, discharge, or death. Of the enrolled infants, 90% (7483) had a known ROP outcome and were included in the study. Median birth weight was 1070 g (range 310-3000g) and mean gestational age 28 weeks (range 22-35 weeks). Severe ROP (Early Treatment of Retinopathy type 1 or 2) developed in 931 infants (12.5%).
CONCLUSION: Successful incorporation of a predictive model into ROP screening requires confidence that it will capture cases of severe ROP. This dataset provides power to estimate sensitivity with half-confidence interval width of less than 0.5%, determined by the high number of severe ROP cases. The G-ROP Study represents a large, diverse cohort of at-risk infants undergoing ROP screening. It will facilitate evaluation of growth-based algorithms to improve efficiency of ROP screening.

Entities:  

Keywords:  Predictive model; prematurity; retinopathy of prematurity; screening

Mesh:

Year:  2016        PMID: 27996334      PMCID: PMC6499901          DOI: 10.1080/09286586.2016.1255765

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  16 in total

1.  Validation of the Children's Hospital of Philadelphia Retinopathy of Prematurity (CHOP ROP) Model.

Authors:  Gil Binenbaum; Gui-Shuang Ying; Lauren A Tomlinson
Journal:  JAMA Ophthalmol       Date:  2017-08-01       Impact factor: 7.389

2.  Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.

Authors:  Graham E Quinn; Gui-Shuang Ying; Edward F Bell; Pamela K Donohue; David Morrison; Lauren A Tomlinson; Gil Binenbaum
Journal:  JAMA Ophthalmol       Date:  2018-12-01       Impact factor: 7.389

3.  Reply.

Authors:  Anne K Jensen; Gil Binenbaum
Journal:  Retina       Date:  2017-05       Impact factor: 4.256

4.  Ocular complications following treatment in the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study.

Authors:  David Morrison; James Shaffer; Gui-Shuang Ying; Gil Binenbaum
Journal:  J AAPOS       Date:  2018-03-14       Impact factor: 1.220

5.  Validation of the Colorado Retinopathy of Prematurity Screening Model.

Authors:  Emily A McCourt; Gui-Shuang Ying; Anne M Lynch; Alan G Palestine; Brandie D Wagner; Erica Wymore; Lauren A Tomlinson; Gil Binenbaum
Journal:  JAMA Ophthalmol       Date:  2018-04-01       Impact factor: 7.389

6.  Development of Modified Screening Criteria for Retinopathy of Prematurity: Primary Results From the Postnatal Growth and Retinopathy of Prematurity Study.

Authors:  Gil Binenbaum; Edward F Bell; Pamela Donohue; Graham Quinn; James Shaffer; Lauren A Tomlinson; Gui-Shuang Ying
Journal:  JAMA Ophthalmol       Date:  2018-09-01       Impact factor: 7.389

Review 7.  The progress of prophylactic treatment in retinopathy of prematurity.

Authors:  Hong-Bing Zhang; Xiao-Dong Wang; Kun Xu; Xiao-Gang Li
Journal:  Int J Ophthalmol       Date:  2018-05-18       Impact factor: 1.779

8.  A Tiered Approach to Retinopathy of Prematurity Screening (TARP) Using a Weight Gain Predictive Model and a Telemedicine System.

Authors:  Jaclyn Gurwin; Lauren A Tomlinson; Graham E Quinn; Gui-Shuang Ying; Agnieshka Baumritter; Gil Binenbaum
Journal:  JAMA Ophthalmol       Date:  2017-02-01       Impact factor: 7.389

9.  Incidence, timing and risk factors of type 1 retinopathy of prematurity in a North American cohort.

Authors:  Yinxi Yu; Lauren A Tomlinson; Gil Binenbaum; Gui-Shuang Ying
Journal:  Br J Ophthalmol       Date:  2020-09-26       Impact factor: 4.638

10.  Association of Surgical Necrotizing Enterocolitis and its Timing with Retinopathy of Prematurity.

Authors:  Jennifer B Fundora; Gil Binenbaum; Lauren Tomlinson; Yinxi Yu; Gui-Shuang Ying; Akhil Maheshwari; Pamela Donohue
Journal:  Am J Perinatol       Date:  2021-08-03       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.